AAAAAA
Results: 26-45/45
Authors:
Mathiot, C
Galon, J
Tartour, E
Teillaud, JL
Facon, T
Bataille, R
Fridman, WH
Sautes, C
Citation: C. Mathiot et al., Soluble CD16 in plasma cell dyscrasias, LEUK LYMPH, 32(5-6), 1999, pp. 467-474
Authors:
Moreau, P
Huynh, A
Facon, T
Bouilly, I
Sotto, JJ
Legros, L
Milpied, N
Attal, M
Bataille, R
Harousseau, JL
Citation: P. Moreau et al., Lack of efficacy of clarithromycin in advanced multiple myeloma, LEUKEMIA, 13(3), 1999, pp. 490-491
Authors:
Puthier, D
Pellat-Deceunynck, C
Barille, S
Robillard, N
Rapp, MJ
Juge-Morineau, N
Harousseau, JL
Bataille, R
Amiot, M
Citation: D. Puthier et al., Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy, LEUKEMIA, 13(2), 1999, pp. 289-294
Authors:
Derenne, S
Amiot, M
Barille, S
Collette, M
Robillard, N
Berthaud, P
Harousseau, JL
Bataille, R
Citation: S. Derenne et al., Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment, J BONE MIN, 14(12), 1999, pp. 2048-2056
Authors:
Moreau, P
Milpied, N
Mahe, B
Juge-Morineau, N
Rapp, MJ
Bataille, R
Harousseau, JL
Citation: P. Moreau et al., Melphalan 220 mg/m(2) followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma, BONE MAR TR, 23(10), 1999, pp. 1003-1006
Authors:
Barille, S
Bataille, R
Rapp, MJ
Harousseau, JL
Amiot, M
Citation: S. Barille et al., Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation, J IMMUNOL, 163(10), 1999, pp. 5723-5728
Authors:
Puthier, D
Bataille, R
Amiot, M
Citation: D. Puthier et al., IL-6 up-regulates Mcl-1 in human myeloma cells through JAK/STAT rather than Ras/MAP kinase pathway, EUR J IMMUN, 29(12), 1999, pp. 3945-3950
Authors:
Avet-Loiseau, H
Facon, T
Daviet, A
Godon, C
Rapp, MJ
Harousseau, JL
Grosbois, B
Bataille, R
Citation: H. Avet-loiseau et al., 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesisof multiple myeloma, CANCER RES, 59(18), 1999, pp. 4546-4550
Authors:
Puthier, D
Derenne, S
Barille, S
Moreau, P
Harousseau, JL
Bataille, R
Amiot, M
Citation: D. Puthier et al., Mcl-1 and Bcl-x(L) are co-regulated by IL-6 in human myeloma cells, BR J HAEM, 107(2), 1999, pp. 392-395
Authors:
Avet-Loiseau, H
Li, JY
Godon, C
Morineau, N
Daviet, A
Harousseau, JL
Facon, T
Bataille, R
Citation: H. Avet-loiseau et al., P53 deletion is not a frequent event in multiple myeloma, BR J HAEM, 106(3), 1999, pp. 717-719
Authors:
Barille, S
Thabard, W
Robillard, N
Moreau, P
Pineau, D
Harousseau, JL
Bataille, R
Amiot, M
Citation: S. Barille et al., CD130 rather than CD126 expression is associated with disease activity in multiple myeloma, BR J HAEM, 106(2), 1999, pp. 532-535
Authors:
Grosbois, B
Jego, P
Attal, M
Payen, C
Rapp, MJ
Fuzibet, JG
Maigre, M
Bataille, R
Citation: B. Grosbois et al., Familial multiple myeloma: report of fifteen families, BR J HAEM, 105(3), 1999, pp. 768-770
Authors:
Avet-Loiseau, H
Li, JY
Morineau, N
Facon, T
Brigaudeau, C
Harousseau, JL
Grosbois, B
Bataille, R
Citation: H. Avet-loiseau et al., Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma, BLOOD, 94(8), 1999, pp. 2583-2589
Authors:
Sahota, SS
Garand, R
Mahroof, R
Smith, A
Juge-Morineau, N
Stevenson, FK
Bataille, R
Citation: Ss. Sahota et al., V-H gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events, BLOOD, 94(3), 1999, pp. 1070-1076
Authors:
Jego, G
Robillard, N
Puthier, D
Amiot, M
Accard, F
Pineau, D
Harousseau, JL
Bataille, R
Pellat-Deceunynck, C
Citation: G. Jego et al., Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells, BLOOD, 94(2), 1999, pp. 701-712
Authors:
Li, JY
Gaillard, F
Moreau, A
Harousseau, JL
Laboisse, C
Milpied, N
Bataille, R
Avet-Loiseau, H
Citation: Jy. Li et al., Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization, AM J PATH, 154(5), 1999, pp. 1449-1452
Authors:
Bataille, R
Citation: R. Bataille, Epidemiology and biology of multiple myeloma, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 593-608
Authors:
Pellat-Deceunynck, C
Barille, S
Jego, G
Puthier, D
Robillard, N
Pineau, D
Rapp, MJ
Harousseau, JL
Amiot, M
Bataille, R
Citation: C. Pellat-deceunynck et al., The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma, LEUKEMIA, 12(12), 1998, pp. 1977-1982
Authors:
Avet-Loiseau, H
Li, JY
Facon, T
Brigaudeau, C
Morineau, N
Maloisel, F
Rapp, MJ
Talmant, P
Trimoreau, F
Jaccard, A
Harousseau, JL
Bataille, R
Citation: H. Avet-loiseau et al., High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) inpatients with plasma cell malignancies, CANCER RES, 58(24), 1998, pp. 5640-5645
Authors:
Costes, V
Portier, M
Lu, ZY
Rossi, JF
Bataille, R
Klein, B
Citation: V. Costes et al., Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production, BR J HAEM, 103(4), 1998, pp. 1152-1160